Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine

NCT00401973 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

199

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorders

Interventions

DRUG: olanzapine
DRUG: amantadine
DRUG: metformin
DRUG: zonisamide
BEHAVIORAL: Wellness education

Sponsor

Eli Lilly and Company